Chk2 Inhibitor II (BML-277) 是一种Chk2的ATP竞争性抑制剂,IC50为15 nM。它对Chk2的选择性比对Chk1和Cdk1/B激酶高1000倍以上。Chk2 Inhibitor II (BML-277) 剂量依赖性地保护人CD4(+)和CD8(+)T细胞免受电离辐射导致的凋亡。
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Chk2 inhibitor II
CAS number:516480-79-8 molecular formula:C20H14CIN3O2
overview
compound introduction
Specs
| Chinese alias | 2-[4-(4-氯苯氧基)苯基]-3H-苯并咪唑-5-羧酰胺 | ||
| English alias | Regadenoson; CVT-3146 | Chk2 Inhibitor II | BML277 | BML-277 | HMS3745A07 | NCGC00165768-02 | NSC741899 | NSC-741899 | 4a9r | ML-277 (Chk2 Inhibitor II) | AKOS000547465 | 2-(4-(4-chlorophenoxy)phenyl)-1H-benzo[d]imidazole-6-carboxamide | AS-55907 | Chk2 I | ||
| CAS number | 516480-79-8 | molecular formula | C20H14CIN3O2 |
| molecular weight | 363.8 g/mol | Exact mass | - |
| PSA | 81.000 Ų | logp | 4.300 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





